OQS
TNDM icon

Occudo Quantitative Strategies’s Tandem Diabetes Care TNDM Stock Holding History

Occudo Quantitative Strategies’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,759
Closed -$244K – 952
2024
Q3 		$244K Sell
5,759
-1,356
-19% -$57.5K 0.04% 529
2024
Q2 		$287K Buy
+7,115
New +$297K 0.05% 477
2023
Q1 		– Sell
-10,265
Closed -$461K – 1202
2022
Q4 		$461K Buy
+10,265
New +$465K 0.05% 526
2022
Q2 		– Sell
-2,684
Closed -$312K – 1378
2022
Q1 		$312K Buy
+2,684
New +$313K 0.03% 802
2021
Q3 		– Sell
-5,619
Closed -$547K – 1148
2021
Q2 		$547K Sell
5,619
-2,394
-30% -$213K 0.08% 400
2021
Q1 		$707K Buy
8,013
+1,486
+23% +$138K 0.15% 223
2020
Q4 		$625K Buy
+6,527
New +$673K 0.2% 169

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Occudo Quantitative Strategies's TNDM Position: Q4 2024 in Review

Occudo Quantitative Strategies sold out of Tandem Diabetes Care (TNDM) in Q4 2024, closing a stake of 5,759 shares — an estimated $244K sold.

Occudo Quantitative Strategies first reported a position in TNDM in Q4 2020 and held it in 7 quarters. The position peaked at $707K in Q1 2021. 316 funds tracked by Wall St. Rank hold TNDM as of Q4 2024.

  • Occudo Quantitative Strategies reported no remaining Tandem Diabetes Care position as of Q4 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 5,759 Tandem Diabetes Care shares in Q4 2024, an estimated $244K.
  • Occudo Quantitative Strategies first reported a position in Tandem Diabetes Care in Q4 2020 and held it in 7 quarters.
  • Occudo Quantitative Strategies's Tandem Diabetes Care position peaked at $707K in Q1 2021.
  • 316 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.